Leukoplakia is defined by the World Health Organization (WHO) as “a white plaque of questionable risk having excluded (other) known diseases or disorders that carry no increased risk...
History of tobacco or alcohol use or oral exposure to irritants
Elicit timing of onset, progression, and presence of pain...
All oral leukoplakias should be treated because they are potentially malignant.
Treatment may include the following:
Some small lesions may respond to cryosurgery.
For 2 to 3 circumscribed lesi...
Follow-up appointments every 3-6 months during the first year following surgical removal, then annually thereafter based on anticipated risk and...
K13.21 Leukoplakia of oral mucosa, including tongue
K13.3 Hairy leukoplakia
414603003 Leukoplakia of oral mucosa
414952002 oral hairy leukoplakia (disorder)
White plaque or patches on the oral mucosa that cannot be rubbed or easily scrapped off
Excisional biopsy is indicated for any undiagnosed leukoplakia.
After treatment, up to 30% of leuk...
Sign up for a 10-day FREE Trial now and receive full access to all content.
Role of Epstein-Barr virus (EBV) in infectious mononucleosis, nasopharyngeal carcinoma, and Burkitt lymphoma. EBV invades and replicates within the salivary glands or pharyngeal epithelium, and is shed into the saliva and respiratory secretions. In some people, the virus transforms pharyngeal epithelial cells, leading to nasopharyngeal carcinoma. In people who are not immune from childhood exposure, EBV causes infectious mononucleosis. EBV infects B lymphocytes, which undergo polyclonal act...
Role of Epstein-Barr virus (EBV) in infectious mononucleosis, nasopharyngeal carcinoma, and Burkitt lymphoma. EBV invades and replicates w...